- Home
- ACEL vs PHVS Comparison
ACEL vs PHVS Comparison
Compare ACEL & PHVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACEL
- PHVS
- Stock Information
- Founded
- ACEL 2009
- PHVS 2015
- Country
- ACEL United States
- PHVS Switzerland
- Employees
- ACEL N/A
- PHVS N/A
- Industry
- ACEL Services-Misc. Amusement & Recreation
- PHVS Biotechnology: Pharmaceutical Preparations
- Sector
- ACEL Consumer Discretionary
- PHVS Health Care
- Exchange
- ACEL Nasdaq
- PHVS Nasdaq
- Market Cap
- ACEL 952.2M
- PHVS 909.5M
- IPO Year
- ACEL N/A
- PHVS 2021
- Fundamental
- Price
- ACEL $11.28
- PHVS $17.99
- Analyst Decision
- ACEL Buy
- PHVS Buy
- Analyst Count
- ACEL 1
- PHVS 6
- Target Price
- ACEL $16.00
- PHVS $37.17
- AVG Volume (30 Days)
- ACEL 241.6K
- PHVS 59.6K
- Earning Date
- ACEL 07-29-2025
- PHVS 08-13-2025
- Dividend Yield
- ACEL N/A
- PHVS N/A
- EPS Growth
- ACEL N/A
- PHVS N/A
- EPS
- ACEL 0.49
- PHVS N/A
- Revenue
- ACEL $1,253,067,000.00
- PHVS N/A
- Revenue This Year
- ACEL $9.02
- PHVS N/A
- Revenue Next Year
- ACEL $4.84
- PHVS N/A
- P/E Ratio
- ACEL $22.90
- PHVS N/A
- Revenue Growth
- ACEL 6.28
- PHVS N/A
- 52 Week Low
- ACEL $9.02
- PHVS $11.51
- 52 Week High
- ACEL $12.96
- PHVS $25.50
- Technical
- Relative Strength Index (RSI)
- ACEL 49.50
- PHVS 58.65
- Support Level
- ACEL $11.01
- PHVS $16.00
- Resistance Level
- ACEL $11.77
- PHVS $17.53
- Average True Range (ATR)
- ACEL 0.22
- PHVS 1.14
- MACD
- ACEL -0.03
- PHVS 0.01
- Stochastic Oscillator
- ACEL 36.29
- PHVS 59.77
About ACEL Accel Entertainment Inc.
Accel Entertainment Inc is a distributed gaming and local entertainment operator in the United States. It is engaged in the installation, maintenance, operation, and servicing of gaming terminals and related equipment, redemption devices that disburse winnings and contain automated teller machine (ATM) functionality, and amusement devices in authorized non-casino locations such as restaurants, bars, taverns, convenience stores, liquor stores, truck stops, and grocery stores. The Company also operates stand-alone ATMs in gaming and non-gaming locations. It generates revenue from Net gaming, Amusement, Manufacturing, ATM fees, and others.
About PHVS Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.